Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse...
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
About this item
Full title
Author / Creator
PRINCIPLE Trial Collaborative Group , Butler, Christopher C , Dorward, Jienchi , Yu, Ly-Mee , Gbinigie, Oghenekome , Hayward, Gail , Saville, Benjamin R , Van Hecke, Oliver , Berry, Nick , Detry, Michelle , Saunders, Christina , Fitzgerald, Mark , Harris, Victoria , Patel, Mahendra G , de Lusignan, Simon , Ogburn, Emma , Evans, Philip H , Thomas, Nicholas PB and Hobbs, FD Richard
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Azithromycin, an antibiotic with potential antiviral and anti-inflammatory properties, has been used to treat COVID-19, but evidence from community randomised trials is lacking. We aimed to assess the effectiveness of azithromycin to treat suspected COVID-19 among people in the community who had an increased risk of complications.
In this UK-bas...
Alternative Titles
Full title
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Authors, Artists and Contributors
Author / Creator
Butler, Christopher C
Dorward, Jienchi
Yu, Ly-Mee
Gbinigie, Oghenekome
Hayward, Gail
Saville, Benjamin R
Van Hecke, Oliver
Berry, Nick
Detry, Michelle
Saunders, Christina
Fitzgerald, Mark
Harris, Victoria
Patel, Mahendra G
de Lusignan, Simon
Ogburn, Emma
Evans, Philip H
Thomas, Nicholas PB
Hobbs, FD Richard
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7972318
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7972318
Other Identifiers
ISSN
0140-6736
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(21)00461-X
